Concepedia

Tenny Mudianto

TM

Statistics

Publications

11

Citations

1.2K

H-Index

11

Active since

2017

Affiliations

New York University(Current)

Dana-Farber Cancer Institute

Washington University in St. Louis

Westlake University

Oregon Health & Science University

Tenny Mudianto is an author at New York University specializing in medicine, immunology, and cell biology.

ORCID

Top concepts

Publications per year

2017–2023

11

Publications

11

Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial

Ravindra Uppaluri, Katie M. Campbell, Ann Marie Egloff et al. · Clinical Cancer Research · 2020 · 342 citations · Full text

Targeting EZH2 Enhances Antigen Presentation, Antitumor Immunity, and Circumvents Anti–PD-1 Resistance in Head and Neck Cancer

Liye Zhou, Tenny Mudianto, Xiaojing Ma et al. · Clinical Cancer Research · 2019 · 252 citations · Full text

SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2

Lu Qiao, Jia Liu, Shuai Zhao et al. · Immunity · 2021 · 165 citations · Full text

, , +9

Suppression of Adaptive Responses to Targeted Cancer Therapy by Transcriptional Repression

Maria Rusan, Kapsok Li, Yvonne Li et al. · Cancer Discovery · 2017 · 140 citations · Full text

Neoadjuvant pembrolizumab in surgically resectable, locally advanced HPV negative head and neck squamous cell carcinoma (HNSCC).

Ravindra Uppaluri, Paul Zolkind, Tianxiang Lin et al. · Journal of Clinical Oncology · 2017 · 77 citations

, , +20

1–5 of 11